Anti-Neuroblastoma Activity of Gold Nanorods Bound with GD2 Monoclonal Antibody under Near-Infrared Laser Irradiation
High-risk neuroblastoma is one of the most common deaths in pediatric oncology. Current treatment of this disease involves a coordinated sequence of chemotherapy, surgery, and radiation. Further advances in therapy will require the targeting of tumor cells in a more selective and efficient way so th...
Main Authors: | Ching-An Peng, Chung-Hao Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/3/1/227/ |
Similar Items
-
Monoclonal Antibody Therapies for High Risk Neuroblastoma
by: Furman WL
Published: (2021-06-01) -
Biocompatible Chitosan Oligosaccharide Modified Gold Nanorods as Highly Effective Photothermal Agents for Ablation of Breast Cancer Cells
by: Panchanathan Manivasagan, et al.
Published: (2018-02-01) -
Effective in Vitro Photokilling by Cell-Adhesive Gold Nanorods
by: Álvaro Artiga, et al.
Published: (2018-06-01) -
Laser thermal therapy is increasingly being used in clinical practice for cancer treatment. Its major limitation is associated with low spatial selectivity. This restriction may be excluded by the use of plasmon-resonant gold nanoparticles as photothermal
by: Chumakov D.S., et al.
Published: (2013-12-01) -
HSP70 Promoter-Driven Activation of Gene Expression for Immunotherapy Using Gold Nanorods and Near Infrared Light
by: Helen A. Andersson, et al.
Published: (2014-03-01)